LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies

You are here

Home » Publications » LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies

LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies

Revilla G, Cedó L, Tondo M, Moral A, Pérez JI, Corcoy R, Lerma E, Fuste V, Reddy ST, Blanco-Vaca F, Mato E, Escolà-Gil JC,
2021
References: 
10.1016/j.semcancer.2020.11.012
  • Associated Personnel
  • Associated Research Groups
  • Associated Departments